Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cyclacel Pharmaceuti (NQ: CYCCP )

8.021 USD UNCHANGED
Last Price Updated: 2:26 PM EDT, Sep 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 8.021
Bid (Size) 7.130 (1)
Ask (Size) 8.030 (5)
Prev. Close 8.021
Today's Range 8.021 - 8.021
52wk Range 4.850 - 11.00
Shares Outstanding N/A
Dividend Yield 7.48%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Cyclacel Pharmaceuticals Presenting at Three Conferences in September
From GlobeNewswire News Releases
Cyclacel Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update
From GlobeNewswire News Releases

Performance

YTD
+14.09%
+14.09%
1 Month
-2.42%
-2.42%
3 Month
-18.16%
-18.16%
6 Month
+1.94%
+1.94%
1 Year
+51.33%
+51.33%

More News

Read More
Cyclacel Pharmaceuticals to Release Second Quarter 2021 Financial Results and Provide Business Update
From GlobeNewswire News Releases
Cyclacel Announces Dosing of First Patient in Phase 1/2 Study of Oral Fadraciclib in Patients With Advanced Solid Tumors and Aggressive Lymphomas
From GlobeNewswire News Releases
Cyclacel Pharmaceuticals to Present at Ladenburg Thalmann’s Virtual 2021 Healthcare Conference
From GlobeNewswire News Releases
Cyclacel Pharmaceuticals Reports First Quarter 2021 Financial Results
From GlobeNewswire News Releases
Cyclacel Pharmaceuticals to Release First Quarter 2021 Financial Results and Provide Business Update
From GlobeNewswire News Releases
Cyclacel Pharmaceuticals Announces Closing of $14.5 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
From GlobeNewswire News Releases
Cyclacel to Present at the Oppenheimer 31st Annual Healthcare Conference
From GlobeNewswire News Releases
Cyclacel Pharmaceuticals Prices $12.65 Million Underwritten Public Offering of Common Stock
From GlobeNewswire News Releases
Cyclacel Pharmaceuticals Announces Proposed Public Offering of Common Stock
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.